•
Sep 30, 2023

Tiptree Q3 2023 Earnings Report

Tiptree's financial performance increased, driven by growth in Fortegra's specialty insurance lines and strategic capital allocation.

Key Takeaways

Tiptree Inc. reported a revenue increase of 14.6% to $416.5 million, primarily driven by Fortegra's specialty insurance lines. Adjusted net income rose by 23.9% to $24.0 million. The company is planning an IPO for its Fortegra subsidiary.

Revenues increased by 14.6% to $416.5 million, driven by growth in Fortegra’s specialty insurance lines.

Net income was $2.2 million, impacted by unrealized losses on investments and lower shipping income.

Adjusted net income increased by 23.9% to $24.0 million, driven by growth in insurance operations.

Tiptree declared a dividend of $0.05 per share.

Total Revenue
$417M
Previous year: $363M
+14.6%
EPS
$0.04
Previous year: $0.38
-89.5%
Gross Profit
$417M
Previous year: $363M
+14.6%
Cash and Equivalents
$515M
Previous year: $503M
+2.2%
Free Cash Flow
$56.3M
Previous year: $114M
-50.7%
Total Assets
$3.19B
Previous year: $3.99B
-20.1%

Tiptree

Tiptree

Forward Guidance

Tiptree intends to take Fortegra public through an IPO, expecting to maintain majority ownership and use the proceeds to support Fortegra's growth.

Positive Outlook

  • Fortegra IPO to be a primary offering.
  • Proceeds to support Fortegra’s growth.
  • Tiptree expects to maintain majority ownership of Fortegra.
  • Fortegra IPO will create a platform to serve the future capital needs of the business.
  • The combined ratio for the quarter was 90.2%, compared to 91.3% in Q3'22.

Challenges Ahead

  • The forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors.
  • Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors.
  • Any initial public offering by Fortegra would be subject to a variety of factors, including market conditions, and may not be consummated.
  • Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date of this release.
  • Other unknown or unpredictable factors also could affect our forward-looking statements.